A Rare Case of Synchronous Lobular Breast Carcinoma and Serous Psammocarcinoma of the Ovary Evaluated by 18F-FDG PET/CT
PDF
Cite
Share
Request
Interesting Image
VOLUME: 34 ISSUE: 1
P: 66 - 69
February 2025

A Rare Case of Synchronous Lobular Breast Carcinoma and Serous Psammocarcinoma of the Ovary Evaluated by 18F-FDG PET/CT

Mol Imaging Radionucl Ther 2025;34(1):66-69
1. Hospices Civils de Lyon, Service de Médecine Nucléaire, Lyon, France
2. Hospices Civils de Lyon, Service de Pathologie Multi-Site, Lyon, France
No information available.
No information available
Received Date: 08.03.2024
Accepted Date: 23.06.2024
Online Date: 07.02.2025
Publish Date: 07.02.2025
PDF
Cite
Share
Request

Abstract

Serous psammocarcinoma of the ovary is a rare variant of ovarian serous carcinoma characterized by the presence of calcified peritoneal lesions, known as psammoma bodies. These calcified lesions may usually be considered benign on computed tomography but may show avidity for 18F-fluorodeoxyglucose (18F-FDG), which can be helpful in the diagnosis of this rare ovarian tumor. We present a rare case of serous psammocarcinoma of the ovary detected during the diagnostic work-up of lobular breast cancer using 18F-FDG positron emission tomography/computed tomography.

Keywords:
Psammocarcinoma, ovary, peritoneum, 18F-FDG PET/CT

Ethics

Informed Consent: A written informed consent was obtained.

Authorship Contributions

Concept: L.A.M., M.D., Design: L.A.M., M.D., Data Collection or Processing: L.A.M., A.T., S.A., A.F., M.D., Analysis or Interpretation: L.A.M., A.T., M.D., Literature Search: L.A.M., M.D., Writing: L.A.M., M.D.
Conflict of Interest: No conflicts of interest were declared by the authors.
Financial Disclosure: The authors declare that this study has received no financial support.

References

1
Liliac L, Carcangiu ML, Canevari S, Căruntu ID, Ciobanu Apostol DG, Danciu M, Onofriescu M, Amălinei C. The value of PAX8 and WT1 molecules in ovarian cancer diagnosis. Rom J Morphol Embryol. 2013;54:17-27.
2
Gilks CB, Bell DA, Scully RE. Serous psammocarcinoma of the ovary and peritoneum. Int J Gynecol Pathol. 1990;9:110-121.
3
Alanbay I, Dede M, Ustün Y, Karaşahin E, Deveci S, Günhan O, Yenen MC. Serous psammocarcinoma of the ovary and peritoneum: two case reports and review of the literature. Arch Gynecol Obstet. 2009;279:931-936.
4
Jena SK, Mishra P, Mohapatra V, Singh S. Bilateral Serous psammocarcinoma of ovary: rare variant low grade serous carcinoma. Case Rep Obstet Gynecol. 2015;2015:531242.
5
Aure JC, Hoeg K, Kolstad P. Psammoma bodies in serous carcinoma of the ovary. A prognostic study. Am J Obstet Gynecol. 1971;109:113-118.
6
Kühn W, Kaufmann M, Feichter GE, Schmid H, Hanke J, Rummel HH. Psammomabody content and DNA-flow cytometric results as prognostic factors in advanced ovarian carcinoma. Eur J Gynaecol Oncol. 1988;9:234-241.
7
Arole VC, Deshpande KA, Jadhav DB, Jogi A. Primary peritoneal psammocarcinoma. J Obstet Gynaecol Res. 2017;43:1366-1372.
8
Mitchell DG, Hill MC, Hill S, Zaloudek C. Serous carcinoma of the ovary: CT identification of metastatic calcified implants. Radiology. 1986;158:649-652.
9
Hiromura T, Tanaka YO, Nishioka T, Tomita K. Serous psammocarcinoma of the ovary: CT and MR findings. J Comput Assist Tomogr. 2007;31:490-492.
10
Ozulker T, Ozulker F, Ozpacaci T. 99mTc-MDP and 18F-FDG uptake in calcified metastatic lesions from ovarian papillary serous adenocarcinoma. Hell J Nucl Med. 2009;12:287-288.
11
Hu SL, Zhou ZR, Zhang YJ. Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases. Abdom Imaging. 2012;37:675-679.
12
Dong A, Wang Y, Zuo C. FDG PET/CT in serous psammocarcinoma of the ovary. Clin Nucl Med. 2014;39:453-455.
13
Inanir S, Oksuzoglu K. FDG PET/CT Imaging of calcified sister mary joseph nodule. Clin Nucl Med. 2016;41:e458-e459.
14
Jeon G, Park SY. Primary peritoneal psammocarcinoma misdiagnosed as an heterotopic ossification: a case report. J Korean Soc Radiol. 2023;84:958-963.